Last week the 2017 MIPS reporting period finally came to a close, which means it’s time to ramp up our 2018 enrollment! SCG Health has been approved as a Qualified Clinical Data Registry (QCDR) for the 2018 reporting year. To help you meet your reporting goals while providing high quality healthcare, we have created the following six measures which will be available for the 2018 reporting year:
SCG1: Evaluation of High Risk Pain Medications for MME
The United States is in the midst of an opioid epidemic and we believe physicians should be doing all they can to help bring it under control. This includes assessing and recording the dosage of those prescribed high-risk medications such as opiates, benzodiazepines, anti-spastics and NSAIDS.
SCG2: Outcome Assessment for Patients Prescribed Ankle Orthosis for Ambulation and Functional Improvement
This outcome measure encourages quality care by allowing the patient’s recovery to affect the final score. The only way for performance to be met in this measure is to document a significant improvement in ankle function, or to confirm that there is no problem with function.
SCG3: outcome Assessment for Patients Prescribed Foot Orthosis for Ambulation and Functional Improvement
Similarly to SCG2, this outcome measure’s score relies on patient recovery. The only way for performance to be met in this measure is to document a significant improvement in foot function, or to confirm that there is no problem with function.
SCG4: Prevention of Antibiotic or Herbal Supplement Impairment of Anesthesia
Many consumers may not be aware that herbal supplements, which are often marketed as being natural and healthy, can have negative interactions with other medications. Because of this, patients may not mention supplements when listing current medications or may be vague saying “I take a vitamin.” Physicians should have a checklist that includes discussing discussing prescribed medications, antibiotic medications and specific herbal supplements, possible complications from combinations of antibiotics or herbal supplements with anesthesia, and ensuring that the surgical team is included with anesthesia impairment prevention and management.
SCG5: Improvement in Quality of Life from Partial Foot, Prosthetics
This measure was created to help physicians quantify how much a patient’s life has been improved by a prosthetic, with the score being based on patient questionnaires. Performance is met if a patient reports that their quality of life has improved or remains the same.
SCG6: Outcome of High Risk Pain Medications Prescribed in the Last Six Months
SCG Health created this measure to help physicians remain aware of the over prescription of dangerous medications such as opioids, benzodiazepines, anti-spastics, and NSAIDS. In order for performance to be met, a patient’s polypharmacy evaluation must result in some sort of prescription change, whether it be a reduction in the number of medications, a change to a different pain management medication or a change in dose or frequency.
If you don’t think you fit these measures, don’t fret! We’ve licensed 21 measures from seven other QCDRs that you may be able to use. Here’s a sneak peak of what other kinds of measures we have to offer:
- MA3 Corneal Abrasion
- ACS18 Patient Frailty Evaluation
- AQI51 Assessment of Patients for Obstructive Sleep Apnea
- CDR2 Diabetic Foot Ulcer (DFU) Healing or Closure
- CODE7 Improved Functional Outcome Assessment for Knee Replacement
- MEX1 Heel Pain Treatment Outcome for Adults
- MSSIC1 Pre-Surgical Screening for Depression
A full list of all the great measures we are offering in 2018 can be found here.